Enhancing Detection of Patients Eligible for Clinical Trials with Pierre Pellier CTMA TRANSCRIPT
Download PDFJun 21, 2021
Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.
Using the CT-Scout platform on a...
Jun 21, 2021
Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.
Using the CT-Scout platform on a...
Using Skunkworks Approach to Get More Drugs Through the Pipeline with Mike Rea Protodigm TRANSCRIPT
Download PDFJun 17, 2021
Mike Rea is the Founder and CEO of IDEA Pharma and Founder of Protodigm, created to develop a new way of progressing drug development. With a fundamental understanding of what goes wrong in early-stage pharmaceutical development, Mike is eager to do more diverse opportunity-seeking for assets in early phase trials. The...
Jun 17, 2021
Mike Rea is the Founder and CEO of IDEA Pharma and Founder of Protodigm, created to develop a new way of progressing drug development. With a fundamental understanding of what goes wrong in early-stage pharmaceutical development, Mike is eager to do more diverse opportunity-seeking for assets in early phase trials. The...
Attacking Rare Disease IgA Nephropathy at the Source in the Gut with Renee Agular-Lucander Calliditas Therapeutics TRANSCRIPT
Download PDFJun 15, 2021
Renee Agular-Lucander is CEO of Calliditas Therapeutics a Sweden-based clinical-stage biopharmaceutical company focused on the rare kidney disease IgA nephropathy. While there is a genetic predisposition for this autoimmune disease, it is still not clear what triggers the condition and there is no current cure.
Renee...